Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.

H, Chemaitelly; P, Tang; MR, Hasan; S, AlMukdad; HM, Yassine; FM, Benslimane; Khatib HA, Al; P, Coyle; HH, Ayoub; Kanaani Z, Al; Kuwari E, Al; A, Jeremijenko; AH, Kaleeckal; AN, Latif; RM, Shaik; Rahim HF, Abdul; GK, Nasrallah; Kuwari MG, Al; Romaihi HE, Al; AA, Butt; MH, Al-Thani; Khal A, Al; R, Bertollini; LJ, Abu-Raddad

doi:10.1056/nejmoa2114114

Public

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.

Shared by NobleBlocks on Oct 6, 2021 • 12:00 AM UTC

Authors:

Chemaitelly H

Tang P

Hasan MR

Abstract

<h4>Background</h4>Waning of vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The persistence of BNT162b2 (Pfizer-BioNTech) vaccine effectiveness against infection and disease in Qatar, where the B....

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!